• Indole-3-pyruvic acid: Research Workflows

  2026-08-30

  Indole-3-pyruvic acid connects plant auxin studies with mechanistic immune assays through a single tryptophan-derived metabolite. This workflow-focused guide explains how to handle IPA, test AhR-dependent effects, and troubleshoot plant, PBMC, and preclinical experiments.

• Forskolin as a cAMP Probe in Trophoblast Stress

  2026-08-29

  Forskolin is an adenylate cyclase activator that can serve as a controlled cAMP perturbation tool in trophoblast stress research. This article connects its established assay applications with new questions raised by the O-GlcNAc–HUWE1–TfR1 ferroptosis axis in preeclampsia.

• CHIR 99021 trihydrochloride for Organoids

  2026-08-28

  Learn how CHIR 99021 trihydrochloride, a selective GSK-3 inhibitor, can be deployed as a tunable input for intestinal organoid expansion, differentiation, and metabolic disease models. This workflow pairs concentration-controlled treatment with practical troubleshooting to improve assay consistency without confusing stemness enhancement with terminal differentiation.

• Telmisartan: Mapping AT1R to Cardiac Remodeling

  2026-08-28

  Telmisartan offers translational researchers a defined AT1-receptor intervention for separating angiotensin II input from downstream cardiac remodeling. This thought-leadership article connects AT1R biology with JAK2/STAT3, NF-κB, and the emerging RIP3/CaMKII axis while providing a practical framework for comparative hypertrophy studies.

• Angiotensin 1/2 (1-6): Assay-First Biology

  2026-08-27

  Explore Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, through an assay-first framework that connects renin-angiotensin system research with cardiovascular and renal biology. Learn how recent binding evidence should shape controls, peptide comparisons, and cross-domain interpretation.

• Ro 3306: A Checkpoint-Aware CDK1 Assay Strategy

  2026-08-27

  Ro 3306 is a selective CDK1 inhibitor for controlled G2/M arrest, cancer cell synchronization, and DNA repair studies. This guide adds a phase-aware framework that connects CDK1 inhibition with mTORC1 state, checkpoint biology, and assay interpretation.

• Indole-3-pyruvic acid: Assay Workflows

  2026-08-26

  Indole-3-pyruvic acid (IPA) connects plant auxin biosynthesis with AhR-focused immune assays. This practical guide shows how to plan IPA experiments, select controls, translate the rheumatoid arthritis findings into workflows, and troubleshoot exposure, viability, and pathway-specific readouts.

• Tauroursodeoxycholic Acid for ER Stress Workflows

  2026-08-26

  Tauroursodeoxycholic Acid, or TUDCA, gives researchers a practical chemical-chaperone approach for separating ER stress, mitochondrial injury, inflammation, and apoptosis in cell and tissue models. This workflow translates recent subarachnoid hemorrhage findings into assay-ready experiments while emphasizing dose control, orthogonal validation, and troubleshooting.

• O-GlcNAcylation Rewires Wnt Bone Formation

  2026-08-25

  The reference study identifies O-GlcNAcylation as a key metabolic effector of Wnt-stimulated osteoblastogenesis. It shows that Wnt3a links calcium and β-catenin signaling to PDK1 stabilization, aerobic glycolysis, bone formation, and fracture healing, providing a mechanistic framework for studying anabolic Wnt biology.

• MEHP, AhR, and Ovarian Follicle Toxicity

  2026-08-25

  A 2024 Biology of Reproduction study identifies aryl hydrocarbon receptor activation as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological blockade with CH223191 partially restored follicle growth, estrogen production, and estrogen-responsive gene expression, linking AhR activity to reproductive disruption.

• Phosbind Acrylamide: Reading Cold Signaling

  2026-08-24

  Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis through phosphate-sensitive mobility shifts in SDS-PAGE. This article applies that assay logic to the calcium-feedback architecture of apple cold signaling and clarifies what gel shifts can—and cannot—prove.

• BMAL1 Phase Separation and Circadian Transcription

  2026-08-24

  Gao et al. show that BMAL1 forms phosphorylation-sensitive nuclear condensates that function as transcriptional hubs rather than acting only as a conventional DNA-binding factor. An N-terminal intrinsically disordered region is required for these assemblies and for restoration of circadian transcription and locomotor rhythms, linking spatial protein organization to clock function.

• BEND Lipids for mRNA Delivery and Gene Editing

  2026-08-23

  The reference study introduces branched endosomal disruptor lipids that improve lipid nanoparticle delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complexes. By combining comparative delivery studies with mechanistic endosomal assays, the authors link terminal lipid branching to enhanced endosomal penetration, hepatic gene editing, and T-cell transfection.

• AM 281 in CB1 Neuropharmacology Workflows

  2026-08-22

  AM 281 provides a selective way to interrogate CB1 signaling in traumatic brain injury, astrocyte glutamate transport, and cognition assays. This workflow-focused guide connects receptor pharmacology with GLT-1, CREB, behavioral, and troubleshooting readouts for more reproducible neuropharmacology research.

• CH 223191 and AhR-Mediated MEHP Ovarian Toxicity

  2026-08-22

  The reference study identifies aryl hydrocarbon receptor activation as a functional contributor to mono(2-ethylhexyl) phthalate-induced defects in mouse ovarian follicles. By combining MEHP exposure with pharmacological AhR blockade, the authors connect receptor activity with impaired follicle growth, estrogen production, and estrogen-responsive gene expression.

7870 records 1/525 page Next 12345 下5页 Last page